𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intravenous iron treatment in paediatric chronic kidney disease patients not on erythropoietin

✍ Scribed by Henry E. G. Morgan; Richard C. L. Holt; Caroline A. Jones; Brian A. Judd

Publisher
Springer
Year
2007
Tongue
English
Weight
74 KB
Volume
22
Category
Article
ISSN
0931-041X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

FDA report: Ferumoxytol for intravenous
FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease
✍ Min Lu; Martin H. Cohen; Dwaine Rieves; Richard Pazdur πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Abstract On June 30, 2009, the United States Food and Drug Administration (FDA) approved ferumoxytol (Ferahemeβ„’ injection, AMAG Pharmaceuticals), an iron‐containing product for intravenous (IV) administration, for the treatment of iron deficiency anemia in adult patients with chronic kidney dise